Jed Latkin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jed Latkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jed Latkin. Jed Latkin is CEO, COO & CFO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and COO and CFO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and Interim COO in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB).
Latest Insider Trading Transactions of Jed Latkin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Option Exercise | A | 2.56 | 100,000 | 256,000 | 100,000 | |
| Aug 18 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Option Exercise | A | 4.70 | 100,000 | 470,000 | 100,000 | |
| Aug 18 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Grant | A | 0.00 | 50,000 | 50 | 107,997 | 58 K to 108 K (+86.21 %) |
| Jun 04 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Grant | A | 2.62 | 33,997 | 89,072 | 57,997 | 24 K to 58 K (+141.65 %) |
| Feb 20 2020 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.08 | 5,000 | 5,400 | 17,950 | 13 K to 18 K (+38.61 %) |
| Jun 07 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.26 | 1,000 | 1,258 | 12,950 | 12 K to 13 K (+8.37 %) |
| May 17 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.46 | 1,000 | 1,463 | 11,950 | 11 K to 12 K (+9.13 %) |
| May 17 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.45 | 1,500 | 2,180 | 10,950 | 9.5 K to 11 K (+15.87 %) |
| May 15 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.45 | 1,000 | 1,448 | 9,450 | 8.5 K to 9.5 K (+11.83 %) |
| May 15 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.84 | 2,000 | 3,679 | 8,450 | 6.5 K to 8.5 K (+31.01 %) |
| May 15 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Buy | P | 1.91 | 2,400 | 4,595 | 6,450 | 4.1 K to 6.5 K (+59.26 %) |
| Feb 11 2019 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | CEO, COO & CFO | Option Exercise | A | 0.00 | 1,000,000 | 0 | 2,065,000 | |
| May 31 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | COO and CFO | Buy | P | 0.44 | 7,600 | 3,317 | 50,159 | 42.6 K to 50.2 K (+17.86 %) |
| May 23 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | COO and CFO | Buy | P | 0.45 | 11,200 | 5,039 | 42,559 | 31.4 K to 42.6 K (+35.72 %) |
| May 23 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | COO and CFO | Buy | P | 0.45 | 14,159 | 6,387 | 31,359 | 17.2 K to 31.4 K (+82.32 %) |
| May 05 2017 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | COO and CFO | Option Exercise | A | 0.00 | 1,000,000 | 0 | 1,065,000 | |
| Nov 01 2016 | NAVB | NAVIDEA BIOPHARMAC ... | Latkin Jed | Interim COO | Option Exercise | A | 1.00 | 20,000 | 20,000 | 20,000 |
Page: 1